• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过皮肤途径递送胰岛素用于糖尿病管理:突破障碍的方法

Delivery of Insulin via Skin Route for the Management of Diabetes Mellitus: Approaches for Breaching the Obstacles.

作者信息

Ahad Abdul, Raish Mohammad, Bin Jardan Yousef A, Al-Mohizea Abdullah M, Al-Jenoobi Fahad I

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

出版信息

Pharmaceutics. 2021 Jan 14;13(1):100. doi: 10.3390/pharmaceutics13010100.

DOI:10.3390/pharmaceutics13010100
PMID:33466845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7830404/
Abstract

Insulin is used for the treatment of diabetes mellitus, which is characterized by hyperglycemia. Subcutaneous injections are the standard mode of delivery for insulin therapy; however, this procedure is very often invasive, which hinders patient compliance, particularly for individuals requiring insulin doses four times a day. Furthermore, cases have been reported of sudden hypoglycemia occurrences following multidose insulin injections. Such an invasive and intensive approach motivates the quest for alternative, more user-friendly insulin administration approaches. For example, transdermal delivery has numerous advantages, such as prolonged drug release, low variability in the drug plasma level, and improved patient compliance. In this paper, the authors summarize different approaches used in transdermal insulin delivery, including microneedles, chemical permeation enhancers, sonophoresis, patches, electroporation, iontophoresis, vesicular formulations, microemulsions, nanoparticles, and microdermabrasion. Transdermal systems for insulin delivery are still being widely researched. The conclusions presented in this paper are extracted from the literature, notably, that the transdermal route could effectively and reliably deliver insulin into the circulatory system. Consistent progress in this area will ensure that some of the aforementioned transdermal insulin delivery systems will be introduced in clinical practice and commercially available in the near future.

摘要

胰岛素用于治疗以高血糖为特征的糖尿病。皮下注射是胰岛素治疗的标准给药方式;然而,这种方法往往具有侵入性,这会妨碍患者的依从性,尤其是对于那些每天需要注射四次胰岛素的个体。此外,有报道称多次注射胰岛素后会突然发生低血糖。这种侵入性和高强度的方法促使人们寻求替代的、更方便用户的胰岛素给药方法。例如,经皮给药有许多优点,如药物释放时间延长、药物血浆水平变异性低以及患者依从性提高。在本文中,作者总结了经皮胰岛素给药中使用的不同方法,包括微针、化学渗透促进剂、超声透入法、贴片、电穿孔、离子电渗疗法、囊泡制剂、微乳剂、纳米颗粒和微晶磨皮术。用于胰岛素给药的经皮系统仍在广泛研究中。本文给出的结论摘自文献,特别是经皮途径能够有效且可靠地将胰岛素输送到循环系统中。该领域的持续进展将确保上述一些经皮胰岛素给药系统在不久的将来引入临床实践并上市销售。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/398b/7830404/d673c094070e/pharmaceutics-13-00100-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/398b/7830404/7a00d57c169b/pharmaceutics-13-00100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/398b/7830404/6c75056ee15c/pharmaceutics-13-00100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/398b/7830404/d673c094070e/pharmaceutics-13-00100-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/398b/7830404/7a00d57c169b/pharmaceutics-13-00100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/398b/7830404/6c75056ee15c/pharmaceutics-13-00100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/398b/7830404/d673c094070e/pharmaceutics-13-00100-g003.jpg

相似文献

1
Delivery of Insulin via Skin Route for the Management of Diabetes Mellitus: Approaches for Breaching the Obstacles.通过皮肤途径递送胰岛素用于糖尿病管理:突破障碍的方法
Pharmaceutics. 2021 Jan 14;13(1):100. doi: 10.3390/pharmaceutics13010100.
2
Transdermal innovations in diabetes management.糖尿病管理中的经皮创新。
Curr Diabetes Rev. 2014;10(6):343-59. doi: 10.2174/1573399810666141124110836.
3
Current Development of Chemical Penetration Enhancers for Transdermal Insulin Delivery.用于经皮胰岛素递送的化学渗透促进剂的当前发展
Biomedicines. 2023 Feb 22;11(3):664. doi: 10.3390/biomedicines11030664.
4
Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery.经皮离子电渗疗法:改善经皮离子电渗药物递送的联合策略。
Eur J Pharm Biopharm. 2005 Jul;60(2):179-91. doi: 10.1016/j.ejpb.2004.12.008.
5
Advances in transdermal insulin delivery.经皮胰岛素传递的进展。
Adv Drug Deliv Rev. 2019 Jan 15;139:51-70. doi: 10.1016/j.addr.2018.12.006. Epub 2018 Dec 8.
6
Nanomaterials for transdermal drug delivery: beyond the state of the art of liposomal structures.用于透皮给药的纳米材料:超越脂质体结构的现有技术水平
J Mater Chem B. 2017 Nov 28;5(44):8653-8675. doi: 10.1039/c7tb02529g. Epub 2017 Nov 1.
7
Transdermal drug delivery.经皮给药
Nat Biotechnol. 2008 Nov;26(11):1261-8. doi: 10.1038/nbt.1504.
8
Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques.各种物理和化学增强技术增强肝素的透皮传递。
Crit Rev Ther Drug Carrier Syst. 2009;26(6):581-606. doi: 10.1615/critrevtherdrugcarriersyst.v26.i6.20.
9
Insights into the percutaneous penetration of antidiabetic agents.抗糖尿病药物经皮渗透的研究进展
J Drug Target. 2017 Feb;25(2):102-111. doi: 10.1080/1061186X.2016.1221956. Epub 2016 Sep 1.
10
Enhanced transdermal drug delivery techniques: an extensive review of patents.增强型经皮给药技术:专利综述
Recent Pat Drug Deliv Formul. 2009 Jun;3(2):105-24. doi: 10.2174/187221109788452285.

引用本文的文献

1
Synthesis and swelling studies of modified chitosan smart hydrogels containing alkyl sulfonate anionic pendant groups as microparticles for insulin release.含烷基磺酸根阴离子侧基的改性壳聚糖智能水凝胶作为胰岛素释放微粒的合成与溶胀研究
Sci Rep. 2025 Jul 18;15(1):26166. doi: 10.1038/s41598-025-06494-9.
2
Harnessing gut cells for functional insulin production: Strategies and challenges.利用肠道细胞进行功能性胰岛素生产:策略与挑战。
Biotechnol Notes. 2022 Dec 9;4:7-13. doi: 10.1016/j.biotno.2022.11.005. eCollection 2023.
3
Effectiveness, safety, and preference of transdermal insulin compared to subcutaneous insulin in the treatment of diabetes patients: a systematic review of clinical trials.

本文引用的文献

1
A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy.用于 1 型糖尿病治疗的溶解型和葡萄糖响应型胰岛素释放微针贴片。
J Mater Chem B. 2021 Jan 28;9(3):648-657. doi: 10.1039/d0tb02133d.
2
Liposomes modified with bio-substances for cancer treatment.经生物物质修饰的用于癌症治疗的脂质体。
Biomater Sci. 2020 Dec 7;8(23):6442-6468. doi: 10.1039/d0bm01531h. Epub 2020 Oct 27.
3
Smart microneedle patches for rapid, and painless transdermal insulin delivery.智能微针贴片,用于快速无痛透皮胰岛素递药。
与皮下注射胰岛素相比,经皮胰岛素治疗糖尿病患者的有效性、安全性及偏好性:一项临床试验的系统评价
Diabetol Metab Syndr. 2024 Aug 17;16(1):197. doi: 10.1186/s13098-024-01442-5.
4
Oral administration microrobots for drug delivery.用于药物递送的口服微型机器人。
Bioact Mater. 2024 May 21;39:163-190. doi: 10.1016/j.bioactmat.2024.05.005. eCollection 2024 Sep.
5
Design, Development and Characterization of Insulin Loaded Topical Pluronic-Lecithin Based Organogel Formulation for the Management of Diabetic Wound.胰岛素负载的基于泊洛沙姆-卵磷脂的局部凝胶制剂的设计、开发和特性评价用于糖尿病创面的管理。
Recent Adv Drug Deliv Formul. 2024;18(1):50-60. doi: 10.2174/0126673878279693231227081931.
6
Fabrication of Black Silicon Microneedle Arrays for High Drug Loading.用于高载药量的黑硅微针阵列的制造
J Funct Biomater. 2023 Apr 26;14(5):245. doi: 10.3390/jfb14050245.
7
Biodegradable double-network GelMA-ACNM hydrogel microneedles for transdermal drug delivery.用于透皮给药的可生物降解双网络GelMA-ACNM水凝胶微针
Front Bioeng Biotechnol. 2023 Jan 25;11:1110604. doi: 10.3389/fbioe.2023.1110604. eCollection 2023.
8
Modulates Glucose, Lipid Peroxidation and Hepatic Metabolism in Streptozotocin-Induced Diabetic Pregnant Rats.调节链脲佐菌素诱导的糖尿病妊娠大鼠的血糖、脂质过氧化和肝脏代谢。
Antioxidants (Basel). 2022 May 24;11(6):1035. doi: 10.3390/antiox11061035.
9
In Silico Prediction of Skin Permeability Using a Two-QSAR Approach.使用双定量构效关系方法对皮肤渗透性进行计算机模拟预测。
Pharmaceutics. 2022 Apr 28;14(5):961. doi: 10.3390/pharmaceutics14050961.
10
Transdermal permeation of curcumin promoted by choline geranate ionic liquid: Potential for the treatment of skin diseases.香叶酸胆碱离子液体促进姜黄素的透皮渗透:治疗皮肤疾病的潜力。
Saudi Pharm J. 2022 Apr;30(4):382-397. doi: 10.1016/j.jsps.2022.01.023. Epub 2022 Feb 4.
J Mater Chem B. 2020 Oct 21;8(40):9335-9342. doi: 10.1039/d0tb01822h.
4
Transfersomes: A Promising Nanoencapsulation Technique for Transdermal Drug Delivery.传递体:一种用于透皮给药的有前景的纳米包封技术。
Pharmaceutics. 2020 Sep 9;12(9):855. doi: 10.3390/pharmaceutics12090855.
5
Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025.全球、地区和国家 195 个国家和地区的糖尿病负担和趋势:1990 年至 2025 年的分析。
Sci Rep. 2020 Sep 8;10(1):14790. doi: 10.1038/s41598-020-71908-9.
6
Drug Delivery System in the Treatment of Diabetes Mellitus.用于治疗糖尿病的药物递送系统
Front Bioeng Biotechnol. 2020 Jul 29;8:880. doi: 10.3389/fbioe.2020.00880. eCollection 2020.
7
Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages.纳米颗粒作为皮肤渗透增强剂和靶向递送载体的潜力:优势与劣势
Drug Des Devel Ther. 2020 Aug 12;14:3271-3289. doi: 10.2147/DDDT.S264648. eCollection 2020.
8
Liposomes: Advancements and innovation in the manufacturing process.脂质体:制造工艺的进步和创新。
Adv Drug Deliv Rev. 2020;154-155:102-122. doi: 10.1016/j.addr.2020.07.002. Epub 2020 Jul 8.
9
Electroporation-enhanced transdermal drug delivery: Effects of logP, pK, solubility and penetration time.电穿孔增强透皮给药:脂水分配系数、解离常数、溶解度和渗透时间的影响
Eur J Pharm Sci. 2020 Aug 1;151:105410. doi: 10.1016/j.ejps.2020.105410. Epub 2020 Jun 4.
10
Transdermal insulin delivery with microwave and fatty acids as permeation enhancers.经皮胰岛素传递与微波和脂肪酸作为渗透增强剂。
Int J Pharm. 2020 Jun 30;584:119416. doi: 10.1016/j.ijpharm.2020.119416. Epub 2020 May 8.